Cakir Mehmet, Cekiç Osman, Yilmaz Omer F
Beyoglu Eye Training and Research Hospital, Istanbul, Turkey.
Ophthalmic Surg Lasers Imaging. 2009 Jul-Aug;40(4):405-8. doi: 10.3928/15428877-20096030-10.
The authors report the result of photodynamic therapy for iatrogenic choroidal neovascularization from focal argon laser photocoagulation in a case with central serous chorioretinopathy. A 45-year-old woman who developed choroidal neovascularization after focal argon laser photocoagulation for chronic central serous chorioretinopathy was treated with ocular photodynamic therapy with verteporfin. Choroidal neovascularization became inactive clinically a month after photodynamic therapy. Fluorescein angiography and optical coherence tomography demonstrated the resolved choroidal neovascularization. Baseline visual acuity improved from 20/40 to 20/20 after photodynamic therapy. The patient's condition remained stable 2 years postoperatively. Photodynamic therapy was beneficial for the outcome of iatrogenic choroidal neovascularization that developed after laser treatment for longstanding central serous chorioretinopathy.
作者报告了1例中心性浆液性脉络膜视网膜病变患者因氩激光局部光凝导致医源性脉络膜新生血管形成后进行光动力治疗的结果。一名45岁女性在因慢性中心性浆液性脉络膜视网膜病变接受氩激光局部光凝后出现脉络膜新生血管形成，接受了维替泊芬眼内光动力治疗。光动力治疗1个月后，脉络膜新生血管在临床上不再活跃。荧光素血管造影和光学相干断层扫描显示脉络膜新生血管已消退。光动力治疗后，基线视力从20/40提高到20/20。术后2年患者病情保持稳定。光动力治疗对长期中心性浆液性脉络膜视网膜病变激光治疗后发生的医源性脉络膜新生血管形成的转归有益。
